
Akshay Patny
EXECUTIVE SUMMARY - DRUG DEVELOPMENT & PROGRAM PORTFOLIO MANAGEMENT LEADERSHIP: ✦ 17+ years of experience - Oncology & Therapeutics... | San Francisco, California, United States
*50 free lookup(s) per month.
No credit card required.
Akshay Patny’s Emails ak****@co****.org
Akshay Patny’s Phone Numbers No phone number available.
Social Media
Akshay Patny’s Location San Francisco, California, United States
Akshay Patny’s Expertise EXECUTIVE SUMMARY - DRUG DEVELOPMENT & PROGRAM PORTFOLIO MANAGEMENT LEADERSHIP: ✦ 17+ years of experience - Oncology & Therapeutics Program & Portfolio Management and Strategy & Insights ✦ Senior Program & Portfolio Management and Strategy & Insights Leader with demonstrated cross-functional, international & leadership experience, strategic & operational skills, and a steadfast drive to advance drug development programs. ✦ Program Management Group Head with experience in managing a diverse team of program managers. ✦ Trusted advisor to senior leaders in R&D & early commercial organization (Heads of Development, Commercial, CMO, CBO, COO). ✦ Therapeutics Thought Leadership: First author for the chapter “The RAS Competitive Landscape” within Elsevier’s upcoming 2024 book ‘RAS Drug Discovery - Past, Present & Future’. ✦ Therapeutics Thought Leadership: CHI 2018 Conference Invited Speaker: ‘Managing Immuno-Oncology Drug Development Programs through Shifting Strategic & Operational Narratives’. ✦ Excellent communication & presentation skills, and an ability to rapidly integrate disparate information, storyboard complex options & scenarios, enabling decision-making discussions within program teams, joint committees, and with executive leadership. ✦ Senior Development Director for RMC-6236, advancing the asset from IND-enabling to early clinical development stage & pivotal registrational plans for pancreatic & lung cancer indications (RASmulti inhibitor - Targeted Oncology). ✦ Development Director for Bavencio (avelumab), advancing the program from early clinical development to submission & launch readiness for lung cancer indication (checkpoint PD-L1 inhibitor - Immuno-Oncology). ✦ Managed submission readiness for Besponsa & Mylotarg assets with product development teams (ADCs - Targeted Chemo). ✦ Led PMO capabilities establishment at small & medium biotech corporations (PM processes, governance, talent recruitment). ✦ Championed numerous special projects, including enterprise PM with PwC, PMO establishment with Accenture, TPP co-development with McKinsey. EXPERTISE / EXPERIENCE AREAS: ✦ Team Management - Direct Reports ✦ Program Management Leadership ✦ Portfolio Management & Strategy ✦ Competitive Intelligence & Insights ✦ Strategic Project Planning & Execution ✦ R&D Governance Management ✦ IND-enabling & Pre-clinical Development ✦ Early & Late-stage Clinical Development ✦ CMC & Diagnostic / Biomarker Development ✦ Global Regulatory Submissions & Launch Readiness ✦ Alliance Management & External Partnerships ✦ Project Management Operations & Processes
Akshay Patny’s Current Industry Revolution Medicines
Akshay
Patny’s Prior Industry
Dr Br Ambedkar Center For Biomedical Research
|
Ranbaxy Laboratories
|
Merck And Co Inc Research Laboratories
|
Pfizer Inc Global R And D
|
Dow Agrosciences Llc The Dow Chemical
|
Ipm Integrated Project Management
|
Emd Serono
|
Biocon Biologics
|
Revolution Medicines
Not the Akshay Patny you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Revolution Medicines
Executive Director | Portfolio Management & Strategy
Fri Sep 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Revolution Medicines
Senior Director | Development PM Group Lead (Oncology)
Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Biocon Biologics
General Manager (Executive Director) | Global PM Head & Group Lead
Mon Jul 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Oct 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Emd Serono
Director | Global Project Leader (Immuno-Oncology) BAVENCIO® (avelumab)
Sat Oct 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jul 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Emd Serono
Associate Director | Senior Global Project Manager (Immuno-Oncology) BAVENCIO® (avelumab)
Fri May 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Sep 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Ipm Integrated Project Management
Management Consultant | Program Manager (Ikaria, Biogen, Pfizer)
Wed May 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri May 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Dow Agrosciences Llc The Dow Chemical
Associate R&D Manager, Global R&D Product Development
Sat Oct 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Apr 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Pfizer Inc Global R And D
Principal Scientist, Inflammation & Immunology R&D
Wed Sep 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Sep 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Pfizer Inc Global R And D
Senior Scientist, Inflammation & Immunology R&D
Sat Sep 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Aug 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Merck And Co Inc Research Laboratories
R&D Intern, Molecular Systems Research / Rare Diseases
Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Aug 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Ranbaxy Laboratories
Medico Marketing Associate
Fri Mar 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jul 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Dr Br Ambedkar Center For Biomedical Research
Summer Undergraduate Research Fellow
Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Aug 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)